PharmaCyte Biotech, Inc.
PMCB · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $31 | $0 | -$4 | -$4 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $1 | $0 |
| Change in WC | $1 | $0 | -$0 | $0 |
| Other Non-Cash | -$35 | -$3 | $0 | $0 |
| Operating Cash Flow | -$3 | -$2 | -$4 | -$4 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$7 | -$5 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$7 | -$5 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $34 | $0 | $87 |
| Stock Repurch. | -$25 | -$44 | -$14 | $0 |
| Dividends Paid | -$1 | $0 | $0 | $0 |
| Other Fin. Act. | -$21 | $0 | $0 | -$0 |
| Financing Cash Flow | -$25 | -$11 | -$14 | $87 |
| Forex Effect | -$0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | -$35 | -$18 | -$17 | $83 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $50 | $68 | $85 | $2 |
| End Cash | $15 | $50 | $68 | $85 |
| Free Cash Flow | -$3 | -$2 | -$4 | -$4 |